GlassScriptPhysician profile
Elvis Xhaferi
NPI 1275850430
$2,878.70
in general payments reported to CMS, 2019-2025
11 companies · $20.52 in 2025
The $20.52 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $276 · 2021: $307 · 2022: $1,112 · 2023: $29.06 · 2024: $102 · 2025: $20.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $102 · Food and Beverage: $49.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $102.37 |
| Food and Beverage | $49.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,170.42 | 2021-2024 | Avenir |
| Stryker Corporation | $879.06 | 2019-2020 | |
| Depuy Synthes Sales INC. | $631.23 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $50.95 | 2020-2022 | |
| Linvatec Corporation | $29.06 | 2023 | Biobrace 23mm |
| Zyla Life Sciences, INC. | $26.04 | 2019-2020 | |
| Ermi LLC | $25.76 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $20.52 | 2025 | |
| Medtronic, INC. | $16.19 | 2021 | |
| Horizon Therapeutics Plc | $15.86 | 2020 | |
| Medtronic USA, INC. | $13.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elvis Xhaferi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.